Lei Duan

Title: Lei Duan: Innovator in Pharmaceutical Composition

Introduction

Lei Duan is a notable inventor based in Evanston, IL (US), recognized for his contributions to the field of pharmaceutical compositions. With a focus on innovative methods for treating diseases, he has secured 2 patents that highlight his expertise and dedication to advancing medical science.

Latest Patents

Duan's latest patents include a method and pharmaceutical composition for inhibiting the PI3K/AKT/mTOR signaling pathway. This method is designed to treat patients suffering from diseases such as cancer, hamartoma syndrome, and hereditary myopathy. The treatment involves administering an effective dose of at least one PRCP and PREP dual antagonist pyridine compound, which can be used alone or in combination with an mTOR inhibitor. Additionally, his patent details a pharmaceutical composition that includes PRCP antagonists, PREP antagonists, or PRCP-PREP dual antagonists, aimed at treating and preventing cancers and diseases related to the insulin receptor substrate protein and the PI3K/AKT/mTOR signaling pathway.

Career Highlights

Duan is currently associated with Targeted Therapeutics, LLC, where he continues to innovate in the pharmaceutical sector. His work is pivotal in developing new therapeutic strategies that can significantly impact patient care and treatment outcomes.

Collaborations

Duan collaborates with esteemed colleagues, including Victor Levenson and Guoguang Ying, who contribute to his research and development efforts.

Conclusion

In summary, Lei Duan is a prominent inventor whose work in pharmaceutical compositions is paving the way for new treatment methodologies. His innovative approaches and collaborations are essential in the ongoing fight against complex diseases.